“Broadly, I think incubations don't work for a number of reasons. I think most firms take too much of the cap table. There's negative selection bias where they don't get the best founders to want to work with them. They can't actually help. And so I broadly think incubations don't work.”
quote is from the automated transcript, cleaned for reading:
filler sounds and stutters are removed, nothing is rephrased. names can be misheard
(the analysis reads context, assessments check outside sources). how →
More from Saam Motamedi
PredictionOpen · timeframe Jul 2029
Motamedi: Current Series B VC vintage overall will not perform well
“Again, Harry, I come back to, unless you're betting that public market multiples are going to re-expand, or that the growth durability of these assets is a lot stronger than what we've seen in the past, the vintage writ large is not going to perform. It does n…”
Saam MotamediJul 15, 2024▶ 49:53Saam Motamedi: Why Series B Won’t Make Money & Why $1M ARR is a BS Milestone for Series A | E1177 · 20VC with Harry Stebbings
Opinion
Saam Motamedi: Most venture capitalists are not helpful
“And our view is most people in Metro Capital are not helpful.”
Saam MotamediJul 15, 2024▶ 0:23Saam Motamedi: Why Series B Won’t Make Money & Why $1M ARR is a BS Milestone for Series A | E1177 · 20VC with Harry Stebbings
Opinion
Saam Motamedi: AI investing is in a crazier bubble than peak ZIRP
“The short answer is yes, we are in a In an exuberant bubble. I think we may not even fully appreciate in how big of a bubble we're in, and what's happening, I could argue, is even crazier than what was happening in peak 2021, 2022 zero interest rate period.”
Saam MotamediJul 15, 2024▶ 3:24Saam Motamedi: Why Series B Won’t Make Money & Why $1M ARR is a BS Milestone for Series A | E1177 · 20VC with Harry Stebbings
Opinion
Motamedi: Right now is the best time in years to invest in SaaS
“I couldn't disagree more. I sincerely believe it is the best time in a long time to be building SaaS companies and investing in SaaS.”
Saam MotamediJul 15, 2024▶ 16:22Saam Motamedi: Why Series B Won’t Make Money & Why $1M ARR is a BS Milestone for Series A | E1177 · 20VC with Harry Stebbings
Opinion
Motamedi: Venture capital signaling risk is total bullshit
“I think it's total bullshit.”
Saam MotamediJul 15, 2024▶ 33:18Saam Motamedi: Why Series B Won’t Make Money & Why $1M ARR is a BS Milestone for Series A | E1177 · 20VC with Harry Stebbings
AssertionNot checkable as stated
Saam Motamedi: Seed rounds frequently hit $100M+ post-money valuations
“It's not unusual for us to see seed rounds for companies that are just getting started being priced in the many tens of millions of dollars, even a hundred million dollar plus post money ranges.”
Saam MotamediJul 15, 2024▶ 0:05Saam Motamedi: Why Series B Won’t Make Money & Why $1M ARR is a BS Milestone for Series A | E1177 · 20VC with Harry Stebbings
Made with StarZero
Turn any episode into a week of clips.
This entire site, over 1,200 episodes transcribed, diarized, checked and made playable,
runs on the StarZero media pipeline. Drop in your own episode and the podcast clipper finds the
moments worth sharing, cuts them, captions them, and reframes them for every feed.
We use essential cookies to make the site work. With your permission we
also use analytics cookies (Google Analytics and Mixpanel) to understand
usage and improve StarZero. See our Cookie Policy.